Research for treatments, prevention and a cure
Page template: single.php
Search terms : 

CTN at AIDS 2018

By July 17, 2018 Uncategorized No Comments

The 22nd International AIDS Conference (AIDS 2018) is the premier gathering for individuals working in the field of HIV, policy makers, people living with HIV, and other individuals committed to ending the pandemic around the world. Attendees of the conference will assess the current state of research, evaluate recent scientific developments, and identify important next steps. This conference takes place every two years, and this year, AIDS 2018 will be taking place in Amsterdam at the RAI Amsterdam from July 23 to July 27. This five-day event will feature a myriad of sessions constituting of special focus sessions, workshops, and oral abstract presentations. The CTN plays an integral part at the conference through our investigators, postdoctoral fellows, and community presenting their material to other professionals.

The AIDS 2018 programme will present new scientific knowledge and offer many opportunities for structured dialogue on the major issues facing the global response to HIV. A variety of session types – from abstract-driven presentations to symposia, and plenary sessions – will meet the needs of various participants. Other related activities include the Global Village, satellite symposia, the Exhibition, and affiliated independent events. Below is a list of conference and pre-conference events that the CTN is involved in, as well as a list of accepted abstracts with contributions from CTN investigators.

Pre-conference and Conference Events


Intensifying the social in the biomedical era: 4thInternational Conference on the Social Sciences and Humanities in HIV
Saturday 21 July Carmen Logie
Keynote – Navigating sex, survival and HIV: Findings from a multi-country program of community-based research with LGBTQ persons
Presentation – Journeys to Self-Acceptance among African, Caribbean and Black
Transgender Women: Insights to Inform Strengths-Based HIV Prevention and Care Cascade Interventions


STI 2018: Understanding and Addressing the HIV and STI Syndemics

Sunday 22 July,

07:30 – 15:00

7:30 AM – 9:00 AM

“Emerging infections”

Marina Klein, McGill University Health Centre, Canada andJürgen Rockstroh, University of Bonn, Germany

Non-Commercial Satellite

Intersectional Stigma: Measurement and Interventions Strategies to Address Multiple Intersecting Stigmas that Potentiate HIV Risks and Limit Engagement in Care


Wednesday 25 July,

18:30 – 20:30


Carmen Logie.

Addressing intersectional stigma: strategies for intervention: 3 8-minutes talks followed by 20-minute moderated discussion





HIV and the liver


Thursday 26 July,

14:30 – 16:00

Co-chairs:Hugo Perazzo, Fundação Oswaldo Cruz (FIOCRUZ), Brazil
Marina Klein, McGill University and CIHR Canadian HIV Trials Network, 

Presentations and Abstracts

Below is a list of oral and poster presentation abstracts from CTN-supported studies, CTN- affiliated researchers, and postdoctoral fellows.

Exhibition Hall
Canada Pavilion
Wednesday, July 25, 14:30 – 15:30
Aslam Anis, Muluba Habanyama, Marina Klein, Renée Masching, Chuck Osborne, Maureen Owino, Kevin Pendergraft, Robert Reinhard, Jean-Pierre Routy.“Best practices for community-scientist collaborations in Canadian HIV research.”

Canada Pavilion
Wednesday 25 July, 13:30 – 14:30
Carmen Logie. “Discussion/commentary/art exhibit about TRANScending Love with images blown up into posters.”

Canada Pavilion
Thursday, July 26, 11:30 – 12:30
Bertrand Lebouché. “The I-Score research program: Designing and evaluating a new patient-reported outcome measure and app for HIV care with stakeholder engagement.”

Global Village
Wednesday 25 July, 16:00 – 17:00
25 Years of Community Leadership in Canadian HIV Research
Muluba Habanyama, Chuck Osborne, Maureen Owino, Kevin Pendergraft.

 Indigenous Networking Zone.
Monday 23 July, 14:00 – 15:30
Marni Amirault, Renée Mashing, Kevin Pendergraft, Kristin Westland. “CAAN and CTN Memorandum of Understanding: An example of two Canadian research networks building bridges.”

Youth Pavilion.
Thursday 26 July, 13:00 – 14:00
The future is female: Women’s leadership in HIV criminalization research and activism [panel discussion] two WATCH team members (Jasmine Cotnam and Marvelous Muchenje) are sitting on this panel – Youth Pavilion Session Room.

WATCH Women: Exposing criminalization of HIV through BodyMapping (Cultural Activity – Art Exhibit) M. Frank, J. Cotnam, S. Greene, A. Ion, L. Birungi, K. Dunn, S. Glum, R. Gormley, M. Muchenje-Marisa, V. Nicholson, J. Odhiambo, K. Shore, A. Symington, A. Kaida

Oral Presentations: (presenting author underlined)

CTN studies

Oral Abstracts
Tuesday 24 July, 13:00 – 14:00
Besieging the reservoir and kicking it where it hurts
Oral Poster Discussion Session Track A – Basic and translational research
Ponte, R.L. Miller, N.N. Kinloch, F.H. Omondi, F.P. Dupuy, R. Fromentin, P. Brassard, V. Mehraj, N. Chomont, A. Poon, Z.L. Brumme, J.-P. Routy, The ORCHID study group
HIV-1 reservoir diversity and genetic compartmentalization in blood and testis. TUPDA0105.

Tuesday 24 July, 14:30 – 16:00
Time for transformation: Listening to trans voices
Oral Abstract Session Track D – Social and political research, law, policy and human rights
Carmen Logie. Developing and pilot testing TRANScending love, a multi-methods arts based workshop with African, Caribbean and Black transgender women. TUAD0405.

Wednesday 25 July, 13:00 – 14:00
All fired up: Tackling inflammation
Oral Poster Discussion Session Track A – Basic and translational research
CTN 257 and CTN 272
J.P. Routy, V. Mehraj, R. Ramendra, C. Costiniuk, B. Lebouché, J. Chen, R. Ponte, R. Thomas, B. Trottier, J. Szabo, P. Coté, R. LeBlanc, J.-G. Baril, N. Bernard, D. Sheppard, C. Chartrand-Lefebvre, M. El-Far, M. Durand, H. Lu, C. Tremblay, Montreal Primary HIV-infection Study and Canadian HIV and Aging Cohort Study Groups. Effect of ART on reducing fungal translocation in HIV-infected patients. WEPDA0102.

Thursday 26 July, 13:00 – 14:00
Restoring immunity and ageing gracefully
Oral Poster Discussion Session Track A – Basic and translational research
Hsieh, B. Sattha, N. Bernard, C. Tremblay, H. Côté, for the CIHR Team on Cellular Aging and HIV Comorbidities in Women and Children (CARMA). Shorter cell subset telomeres in HIV slow progressors than in HIV non-slow progressor women. THPDA0102.

Posters Exhibition (presenting author underlined)
Daily Poster viewing: 12:30 pm – 2:30 pm
Daily Poster discussion: 1 pm – 2 pm

Tuesday, July 24

A. Rich, P. Sereda, M. Ye, J. Zhu, A. Scheim, C. Cooper, S. Walmsley, M. Klein, S. Sanche, D. Kelly, S. Rourke, N. Machouf, R. Hogg, on behalf of the Canadian Observational Cohort Collaboration.The 2014 HIV care cascade and virologic response over time among transgender people in a large multi-site Canadian cohort. TUPEC208.

CTN 262
Carter, S. Greene, D. Money, M. Sanchez, K. Webster, V. Nicholson, L.A. Brotto, C. Hankins, M. Kestler, N. Pick, K. Salters, K. Proulx-Boucher, N. O’Brien, S. Patterson, L. Wang, L. Tiamiyu, A. de Pokomandy, M. Loutfy, A. Kaida, CHIWOS Research Team. Understanding anxiety during sex among women living with HIV in Canada: a cross-sectional analysis of social, psychological, and relational factors. TUPED402.

CTN 262
A. Lacombe-Duncan1,Y. Persad.A qualitative study of intersectional stigma and discrimination of transgender women living with HIV: Implications for HIV vulnerability and access to HIV-related care. TUPED494.

C.H. Logie, C. Williams, Y. Wang, N. Marcus, M. Kazemi, L. Cioppa, A. Kaida, T. Conway, K. Webster, K. Beaver, A. de Pokomandy, M. Loutfy, Y. Persad. A psychosocial approach to understanding pathways from depression to HIV care cascade outcomes among women living with HIV in Canada. TUPED421. 

N.J. Lachowsky, H.L. Armstrong, S. Pan, N. Bacani, G. Olarewaju, E.A. Roth, R.S. Hogg, D.M. Moore. HIV Incidence and Associated Factors Among Men Who Have Sex With Men (MSM) in a Treatment as Prevention Environment: Benefits of a Prospective Cohort Study and Administrative Health Data Linkage. TUPEC262.

J. Cotnam, S. Greene, A. Ion, L. Birungi, K. Dunn, M. Frank, S. Glum, R. Gormley, M. Muchenje-Marisa, V. Nicholson, J. Odhiambo, K. Shore, A. Symington, A. Kaida.Women, ART and the criminalization of HIV non-disclosure (WATCH): Mapping criminalization’s creep into the health and social care of women living with HIV in Canada; Poster Presentation. TUPED474.

Wednesday, July 25

CTN 222
N. Kronfli, R. Nitulescu, J. Cox, E. Moodie, C. Cooper, A. Wong, S. Walmsley, M.B. Klein, on behalf of the Canadian Co-Infection Cohort Investigators. Decreased hepatitis C virus (HCV) treatment uptake among HIV-HCV co-infected patients in Canada with a history of incarceration. WEPEB091.

CTN 222
S. Saeed, E. Strumpf, E. Moodie, J. Cox, M. Tyndall, C. Cooper, M. Hull, L. Barrett, V. Martel-Laferriere, M. Klein, Canadian HIV/HCV Co-Infection Cohort Study. Impact of fibrosis stage restrictions on hepatitis C (HCV) treatment initiation rates: overall and among PWID in HIV-HCV co-infected populations in Canada. WEPEB096.

CTN 262
N. Kronfli, N. O’Brien, K. Proulx-Boucher, D. Rouleau, M. Loutfy, A. Kaida, M. Ndung’u, B. Gagnier, H. Dubinsky, M. Lee, A. de Pokomandy, on behalf of the CHIWOS Research Team. Trends in antiretroviral switching and discontinuation among Canadian women living with HIV. WEPEB114.

CTN 262
M. Shokoohi, G. R. Bauer, A. Kaida, A. Lacombe-Duncan, M. Kazemi, B. Gagnier, A. de Pokomandy, M. Loutfy,R. Gormley, on behalf of the CHIWOS Research Team. Social determinants of health and self-rated health status: a comparison between women with HIV and women without HIV from the general population in Canada. WEPED333.

 CTN 262
A. Lacombe-Duncan, G. Bauer, P.A. Newman, C.H. Logie, Y. Persad, M. Shokoohi, A. Kaida, A. de Pokomandy, N. O’Brien, M. Loutfy. The HIV care cascade among trans women in Canada: barriers and facilitators. WEPED518.

C.H. Logie, Y. Wang, N. Marcus, K. Levermore, N. Jones, T. Ellis. Pathways from multiple syndemic conditions to HIV vulnerabilities and protective factors among transgender, gay, lesbian and bisexual persons in Jamaica. WEPED338.

Thursday, July 26

M. Hull, T. Grennan, J. Wong, S. Guillemi, W. Zhang, V. Lima, T. Consalacion, P. Sereda, M. Gilbert, M. Krajden, J. Montaner, R. Hogg, G. Ogilvie. Outcomes of expedited initiation of antiretroviral therapy (ART) in individuals with acute HIV infection, British Columbia, Canada. THPEB035.

CTN 281
F. Kakkar, J. Brophy, T. Lee, M. Hawkes, L. Samson, S. Read, H. Soudeyns, A. Bitnun, EPIC4 Study Team. Challenges to achieving and maintaining sustained viral suppression among HIV infected Canadian children. THPEB131.

M.J. Trahan, M.E. Metras, S. Valois, C. Renaud, V. Lamarre, F. Kakkar.
Antiretroviral prophylaxis for infants of drug-resistant perinatally HIV infected (PHIV) women. THPEB137.

N.J. Lachowsky, L. Wang, N. Bacani, S. Chown, K.A. Closson, H.L. Armstrong, K.G. Card, G. Olarewaju, E.A. Roth, R.S. Hogg, D.M. Moore, Momentum Health Study
Differential Trends in Biomedical HIV Prevention Among Younger and Older Men Who Have Sex With Men in a Treatment as Prevention Environment: A 5-Year Prospective Cohort Study. THPEC279.

S.B. Rourke, T. Bekele, J. Globerman, J. Watson, S.W. Hwang, K. Hambly, J. Koornstra, G. Walker, J. Bacon, Positive Spaces, Healthy Places Study Team. Homelessness and incarceration are associated with elevated mortality rate among people living with HIV in Ontario, Canada: findings from the CIHR-funded positive spaces, healthy places study. THPED524.

N. Nashid
, F. Kordy, S. Khan, S. Read, G. McDougall, D. Louch, C. Arneson, S.A. Bitnun.Video directly observed therapy to improve adherence of human immunodeficiency infected children and adolescents to combination antiretroviral therapy: A pilot study. THPEB126.

Research for treatments, prevention and a cure